Loading candles…
Bio Medica Laboratories, incorporated on August 14, 2015, operates in the pharmaceutical manufacturing industry. The company specializes in manufacturing pharmaceutical injectable formulations for both human and veterinary use, adopting a business-to-business contract manufacturing model. Its production includes liquid and dry powder injections, carried out in Good Manufacturing Practice (GMP) and Good Laboratory Practice (GLP) certified facilities. The company's facilities are also equipped with advanced quality testing infrastructure to ensure product standards. No information on founders, key management, geographic presence, subsidiaries, or stock listings is provided.
This page is a live market overview for BIO MEDICA LABORATORIES L (BMLL) on the NSE. As a listed security, BIO MEDICA LABORATORIES L is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for BMLL before placing trades on tick2trade.
As of the latest feed, BMLL last traded at ₹145.95 on NSE, down ₹4.1 (2.73%) from the previous close of ₹150.05. Today's session range is ₹145 – ₹157.25, against a 52-week band of ₹101.5 – ₹162.1. Traded volume today stands at 78.00K shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for BMLL in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether BMLL is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for BIO MEDICA LABORATORIES L before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in BMLL. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated BMLL option chain page linked from this overview.
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.